InflammaDry is the only test that detects elevated levels of MMP-9, a key inflammatory
marker for dry eye. This rapid, point-of-care test produces results in 10 minutes allowing
patients to be tested and treated in the same office visit. The test is easy to perform, is
minimally invasive and requires no additional equipment. InflammaDry utilizes innovative
patented technology, is CE marked, and CLIA waived.
Quidel is a long-standing leader in the manufacture and sale of rapid, point-of-care
diagnostics. Contact your Quidel Account Manager today at 800.874.1517 to learn more
about how InflammaDry can help improve the health of your dry eye patients.
The One and Only Indicator of
MMP-9 for Dry Eye Inflammation
quideleyehealth.com
AD1023202EN00
(05/19)
